BridgeBio Pharma is a biopharmaceutical company focused on discovering and delivering transformative medicines for genetic diseases and genetically defined cancers. Utilizing a 'moneyball for biotech' approach, we minimize risk and drive innovation through small expert teams, creating a robust portfolio of over 20 drug development programs to address unmet medical needs.
